mergers and acquisitions

Praemium holds significant strategic value as a leader in the HNW segment and is worth $1-$1.40/share in the event of a sale.

Michael discusses the adviser shortage, advice firm valuations & how growth advisers are building scalable firms through acquisition.

Focusing on acquisition makes sense at certain times in the mining cycle. James Cooper believes markets are on track to hit that in 2026

The preliminary decision to block Cosette's acquisition of Mayne Pharma sets a bad precedent and would weaken Australia's capital markets.

Will FIRB kibosh Cosette's acquisition of Mayne Pharma?

Why we are invested in Greatland Gold

The sale of Anglo American's Australian coal portfolio will provide a strong leading indicator to the global economic outlook

M&A to surge as private equity adapts to normalised valuations, capital distributions, and technology trends

Aussie Broadband (ASX:ABB) continues to make strides in the Australian broadband sector.

Macquarie has reviewed the Sigma-CWG merger against the recent jump in Sigma Healthcare shares, forming a dim view of the stock's valuation.